The cost-effectiveness of antenatal malaria prevention in sub-Saharan Africa

American Journal of Tropical Medicine and Hygiene

Volumn 64, Issue 1-2 SUPPL., 2001, Pages 45-56

  Goodman, C A ^a   Coleman, P G ^a   Mills, A J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR;

AFRICA; CHEMOPROPHYLAXIS; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG COST; FEMALE; HUMAN; MALARIA; MALARIA CONTROL; PATIENT COMPLIANCE; PRIMIGRAVIDA;

PROTOZOA;

EID: 0034968392     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.64.45     Document Type: Conference Paper

References (71)

1. Epidemiological and control issues related to malaria in pregnancy
2. Developing effective strategies for malaria prevention programs for pregnant African women
3. Malaria is an important cause of anaemia in primigravidae: Evidence from a district hospital in coastal Kenya
4. An analysis of malaria in pregnancy in Africa
5. Epidemiology, malaria and pregnancy
6. The contribution of low birth weight to infant mortality and childhood morbidity
7. Can malaria chemoprophylaxis be restricted to first pregnancies?
8. Malaria in pregnancy in endemic areas
9. Antenatal chloroquine chemoprophylaxis in Malawi: Chloroquine resistance, compliance, protective efficacy and cost
10. Malaria chemoprophylaxis compliance in pregnant women: A cost-effectiveness analysis of alternative interventions
11. Anti-malarials during pregnancy: A cost-effectiveness analysis
12. Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: Chloroquine and sulfadoxine-pyrimethamine
13. Review article: The evidence base on the cost-effectiveness of malaria control measures in Africa
14. Cost-effectiveness of malaria control in sub-Saharan Africa
15. Birthweight and perinatal mortality. I: On the frequency distribution of birthweight
16. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy
17. Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae
18. Increase of birth weight following chloroquine chemoprophylaxis during the first pregnancy: Results of a randomized trial in Cameroon
19. The prevention of anaemia in pregnancy in primigravidae in the Guinea savanna of Nigeria
20. Interventions for the control of diarrhoeal diseases among young children: Prevention of low birth weight
21. Malaria chemoprophylaxis, birth weight and child survival
22. The effect of placental malaria infection on perinatal-mortality in rural Malawi
23. Birthweight and perinatal mortality. II: On weight-specific mortality
24. Birthweight and perinatal mortality. III: Towards a new method of analysis
25. Maximum-likelihood for parasitologists
26. The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women
27. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi
28. Intermittent sulfadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomised placebo-controlled trial
29. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis
30. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection
31. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi
32. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach
33. Cost-effectiveness of malaria control in sub-Saharan Africa
34. The effect of malaria and malaria prevention in pregnancy on offspring birth-weight, prematurity, and intrauterine growth-retardation in rural Malawi
35. Thoughts on malaria in pregnancy with consideration of some factors which influence remedial strategies
36. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control
37. Maternal HIV infection and infant mortality in Malawi: Evidence for increased mortality due to placental malaria infection
38. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1
39. Management and health care reform in sub-Saharan Africa
40. Costs of primary health care at the Alexandra Health Centre
41. Delivering at the right price - The costs of primary maternity care at the Diepkloof Community Health Centre, Soweto
42. The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and provided by community health workers in Saradidi, Kenya. I: Reasons for non-acceptance
43. Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. I. Reasons for non-acceptance
44. Pricing, distribution, and use of antimalarial drugs
45. A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, West Africa. 8: Cost-effectiveness of bed net impregnation alone or combined with chemoprophylaxis in preventing mortality and morbidity from malaria in Gambian children
46. Costs and financing of improvements in the quality of maternal health services through the Bamako Initiative in Nigeria
47. Comparability of treatment groups and risk-factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi
48. Perception and utilisation of malaria prophylaxis among pregnant women in Dar es Salaam, Tanzania